Tribute Pharmaceuticals Canada Inc (SLRXF) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
544 EGERTON ST LONDON, ON N5W 3Z8 |
| State of Incorp. | ON |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 17,600 | 5,551 | 3,506 | 28,726 | 2,302 | 3,073 | |||
| Cash and cash equivalents | 17,600 | 5,551 | 3,506 | 28,726 | 2,302 | 3,073 | |||
| Receivables | 5,600 | 3,124 | 2,145 | 1,923 | 1,947 | 1,657 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,922 | 1,194 | 1,037 | 857 | 1,059 | 1,104 | |||
| Inventory | 2,922 | 1,194 | 1,037 | 857 | 1,059 | 1,104 | |||
| Prepaid expense | 408 | 221 | 180 | 226 | 186 | 169 | |||
| Deferred costs | 1,213 | 140 | 128 | 122 | 117 | 119 | |||
| Other current assets | 43 | 13 | |||||||
| Other undisclosed current assets | 571 | 142 | 153 | 70 | 201 | 145 | |||
| Total current assets: | 28,314 | 10,415 | 7,150 | 31,937 | 5,812 | 6,266 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1,296 | 979 | 1,012 | 1,026 | 1,055 | 1,076 | |||
| Intangible assets, net (including goodwill) | 88,057 | 44,063 | 44,558 | 12,978 | 13,221 | 13,081 | |||
| Goodwill | 7,532 | 3,599 | 3,599 | 3,599 | 3,599 | 3,599 | |||
| Intangible assets, net (excluding goodwill) | 80,525 | 40,464 | 40,959 | 9,379 | 9,622 | 9,482 | |||
| Deferred costs | 326 | 366 | 287 | 302 | 342 | ||||
| Other undisclosed noncurrent assets | 359 | ||||||||
| Total noncurrent assets: | 89,679 | 45,409 | 45,929 | 14,291 | 14,578 | 14,499 | |||
| TOTAL ASSETS: | 117,993 | 55,824 | 53,080 | 46,228 | 20,390 | 20,765 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 8,793 | 4,287 | 4,345 | 3,341 | 4,057 | 3,092 | |||
| Other undisclosed accounts payable and accrued liabilities | 8,793 | 4,287 | 4,345 | 3,341 | 4,057 | 3,092 | |||
| Debt | 12,500 | 1,526 | 1,319 | 737 | 583 | 346 | |||
| Derivative instruments and hedges, liabilities | 9,575 | 5,359 | 3,108 | 3,251 | 7,705 | 4,499 | |||
| Other liabilities | 25 | 189 | 103 | ||||||
| Other undisclosed current liabilities | 19,093 | ||||||||
| Total current liabilities: | 49,987 | 11,172 | 8,772 | 7,329 | 12,535 | 8,041 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 14,507 | 15,261 | 13,967 | 7,645 | 7,366 | 7,849 | |||
| Long-term debt, excluding current maturities | 14,507 | 15,261 | 13,967 | 7,645 | 7,366 | 7,849 | |||
| Liabilities, other than long-term debt | 7,594 | ||||||||
| Deferred tax liabilities, net | 7,594 | ||||||||
| Total noncurrent liabilities: | 22,102 | 15,261 | 13,967 | 7,645 | 7,366 | 7,849 | |||
| Total liabilities: | 72,088 | 26,433 | 22,739 | 14,974 | 19,901 | 15,890 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 45,905 | 29,391 | 30,341 | 31,254 | 489 | 4,876 | |||
| Common stock | 71,099 | 45,022 | 41,183 | 41,189 | 20,159 | 20,159 | |||
| Additional paid in capital | 3,737 | 3,062 | 2,714 | 2,647 | 2,504 | 2,404 | |||
| Accumulated other comprehensive income (loss) | (25) | 43 | 13 | (189) | (103) | ||||
| Accumulated deficit | (33,909) | (25,084) | (19,903) | (18,943) | (21,985) | (17,584) | |||
| Warrants and rights outstanding | 6,347 | ||||||||
| Other undisclosed equity, attributable to parent | 5,003 | 6,347 | 6,347 | ||||||
| Total equity: | 45,905 | 29,391 | 30,341 | 31,254 | 489 | 4,876 | |||
| TOTAL LIABILITIES AND EQUITY: | 117,993 | 55,824 | 53,080 | 46,228 | 20,390 | 20,765 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 6,429 | 5,592 | 5,468 | 3,869 | 4,041 | 3,494 | ||
| Revenue, net | 6,429 | 5,592 | 5,468 | 3,869 | 4,041 | 3,530 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (780) | (575) | (535) | (438) | (351) | (346) | ||
| Other undisclosed gross profit | (1,546) | (1,452) | (1,459) | (1,550) | (1,650) | (1,413) | ||
| Gross profit: | 4,104 | 3,565 | 3,474 | 1,880 | 2,040 | 1,735 | ||
| Operating expenses | (5,025) | (3,948) | (2,615) | (2,826) | (2,706) | (3,513) | ||
| Operating income (loss): | (921) | (383) | 858 | (946) | (666) | (1,778) | ||
| Nonoperating income (expense) | (6,099) | (4,129) | 234 | 4,227 | (3,195) | 1,608 | ||
| Investment income, nonoperating | (6,182) | (2,696) | 4,455 | (3,206) | 1,412 | |||
| Gain (loss), foreign currency transaction, before tax | 337 | (1,433) | (228) | 11 | 196 | |||
| Other nonoperating expense | (254) | |||||||
| Interest and debt expense | (595) | (596) | (573) | (304) | (298) | (267) | ||
| Income (loss) from continuing operations: | (7,615) | (5,108) | 520 | 2,977 | (4,159) | (438) | ||
| Income (loss) before gain (loss) on sale of properties: | (7,615) | (5,108) | 520 | 2,977 | (4,159) | (438) | ||
| Net income (loss): | (7,615) | (5,108) | 520 | 2,977 | (4,159) | (438) | ||
| Other undisclosed net income (loss) attributable to parent | (1,210) | (74) | (1,479) | (2,850) | ||||
| Net income (loss) attributable to parent: | (8,825) | (5,181) | (960) | 2,977 | (4,159) | (3,288) | ||
| Other undisclosed net income (loss) available to common stockholders, basic | 0 | 65 | (242) | |||||
| Net income (loss) available to common stockholders, diluted: | (8,825) | (5,181) | (960) | 3,042 | (4,401) | (3,288) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2015 Q3 | 6/30/2015 Q2 | 3/31/2015 Q1 | 12/31/2014 Q4 | 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (7,615) | (5,108) | 520 | 2,977 | (4,159) | (438) | ||
| Comprehensive income (loss): | (7,615) | (5,108) | 520 | 2,977 | (4,159) | (438) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (1,235) | (74) | (1,479) | 65 | (242) | (2,850) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (8,850) | (5,181) | (960) | 3,042 | (4,401) | (3,288) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.